We bring deep expertise at the boundary between discovery and clinical development — the stage where most projects face their highest translational risk.
Defining which biomarkers to develop, when, and to what standard. From target engagement markers in preclinical studies to patient selection markers for clinical trials.
Bridging the gap between animal models and human biology. Ensuring your preclinical data package answers the right questions before you move to the clinic.
Building the scientific foundation for patient stratification — from hypothesis generation through biomarker development and companion diagnostic strategy.
Protocol design, endpoint selection, and go/no-go decision frameworks. Making sure your clinical programme is designed to generate interpretable data.
Objective, critical review of preclinical and clinical data. An external perspective that challenges assumptions and surfaces risks before they become problems.
Preparing for and maximising the value of scientific advisory board meetings. Ensuring you ask the right questions and act on the answers.
We don't produce reports and move on. We embed in your project team for the duration of the engagement — attending team meetings, reviewing data in real time, and being available for the unscheduled conversations that matter most.
This approach means we develop genuine context about your project, your team, and the decisions you face. That context is what makes the difference between generic advice and genuinely useful scientific partnership.
Engagements typically run from three months to two years, depending on the stage and scope of the project. We work with a small number of clients at a time to ensure we can provide the depth of attention each programme deserves.
Schedule a call to discuss your discovery project and build an objective, data-driven path to the clinic.
Book a free consultation